European Union was Anbio Biotechnology’s largest region in fiscal 2025, bringing in $5.15M of $8.65M (60%).
| Geography | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| European Union | $20.30M | $4.66M | $5.62M | $5.15M |
| Asia Pacific | $3.19M | $73.40K | $509.17K | $1.52M |
| South America | — | $1.65M | $1.48M | $269.54K |
| Other Regions | — | $111.05K | $472.38K | $1.41M |
| North America | $50.00K | $215.44K | $110.51K | $296.20K |
| Total | $23.54M | $6.71M | $8.19M | $8.65M |
Anbio Biotechnology brought in $8.65M from its five regions in fiscal 2025, the year ended December 31, 2025. That was up 5.6% from $8.19M in fiscal 2024. European Union was the largest at $5.15M (59.6%), ahead of Asia Pacific at $1.52M (17.6%) and Other Regions at $1.41M (16.3%). The other two regions brought in $565.74K combined.
Compared with fiscal 2024, Asia Pacific grew fastest, up 198.6% to $1.52M, while South America fell the most, down 81.7% to $269.54K.
Anbio Biotechnology began breaking out South America in fiscal 2023 and Other Regions in fiscal 2023.
Anbio Biotechnology (NNNN) reports its revenue by geography. In fiscal 2025, European Union was its largest region, bringing in $5.15M (59.6% of the total), followed by Asia Pacific at $1.52M (17.6%).
European Union was Anbio Biotechnology's largest region in fiscal 2025, bringing in $5.15M, or 59.6% of the $8.65M total across its five regions.
Among Anbio Biotechnology's regions that make up at least 2% of revenue, Asia Pacific grew fastest in fiscal 2025, up 198.6% from $509.17K to $1.52M.
Every figure comes from Anbio Biotechnology's annual financial filings, as reported. Each line keeps the name Anbio Biotechnology gives it, and years follow its fiscal calendar.
Anbio Biotechnology's revenue by geography goes back to fiscal 2022, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.